arrow
P

Pier Giorgio Cojutti

Department of Medical and Surgical Sciences
H指数:29
被引数:2,894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimising tazobactam dosing in critically ill adult patients without renal replacement therapy: a population pharmacokinetic analysis of individual patient data pooled from multiple clinical studies

优化未接受肾脏替代治疗的危重成人患者他唑巴坦给药剂量:一项基于多中心临床研究个体患者数据合并的群体药代动力学分析

2026-09-090
OA
Relationship between continuous infusion meropenem PK/PD target attainment and C-reactive protein dynamics in onco-haematologic patients with febrile neutropenia

连续输注美罗培南PK/PD目标达成与发热性中性粒细胞减少症血液肿瘤患者C反应蛋白动力学之间的关系

2026-07-020
OAAI
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?

积极联合药代动力学/药效学靶点达成为治疗剂量监测指导下的美罗培南-伐博巴坦单药持续输注:这是最大化KPC产生肠杆菌科细菌感染微生物学疗效的有价值策略吗?

2026-04-170
OAAI
Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction?

高剂量达托霉素与持续输注西托比罗尔联合应用在已确诊金黄色葡萄球菌菌血症或心内膜炎病例系列中的药代动力学/药效学分析:是否有根据治疗药物监测指导的给药剂量减少的余地?

2026-03-190
OA
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis

24小时连续输注铁皮诺卡因(cefiderocol)通过弹性泵给药在实现NDM产酶肺炎克雷伯菌(Klebsiella pneumoniae)乳突炎治疗中的PK/PD目标可行性

2025-05-050
OA
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections
2025-02-240
OAAI
Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia

增加他唑巴坦浓度对哌拉西林对产生ESBL的肠杆菌的杀菌活性的影响引起菌血症的临床分离株

2024-07-170
PRE
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study
2023-03-220
OAAI